VK2735 has specific liver fat reduction properties that are promising. See #msg-173042423. Time will tell if it also has an a "clinically meaningful" effect on fibrosis like the dual GLP1-GIP agonist trizepatide which does not exist as an oral.
Picking any small molecule GLP1 is not likely to be as effective.
"People are best convinced by reasons they discover themselves"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.